Cargando…

PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling

BACKGROUND: Peroxiredoxin 1 (PRDX1) has been identified as a dual regulator of tumorigenesis. However, its expression, clinical significance, and biological function in nasopharyngeal carcinoma (NPC) remain unknown. This study aimed to explore the role and underlying mechanisms of PRDX1 in NPC. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Hongmei, Yang, Taoyu, Yan, Lingli, Feng, Jihong, Huang, Boyan, Jiang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501964/ https://www.ncbi.nlm.nih.gov/pubmed/32982301 http://dx.doi.org/10.2147/OTT.S252286

Ejemplares similares

TGFβ activates PI3K-AKT signaling via TRAF6
por: Song, Jie, et al.
Publicado: (2017)

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
por: Cao, Juxiang, et al.
Publicado: (2009)

Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway
por: Xu, Jun, et al.
Publicado: (2017)

Centipeda minima (Ebushicao) extract inhibits PI3K-Akt-mTOR signaling in nasopharyngeal carcinoma CNE-1 cells
por: Guo, Yu-qing, et al.
Publicado: (2015)

SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway
por: Wang, Ying, et al.
Publicado: (2023)

MicroRNA-122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro
por: Yang, Yan, et al.
Publicado: (2018)

TRAF4 Regulates Migration, Invasion, and Epithelial–Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma
por: Liu, Kairui, et al.
Publicado: (2017)

Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma
por: Lin, Lie-Hao, et al.
Publicado: (2017)

YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling
por: Fan, Xiaoqin, et al.
Publicado: (2021)

FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway
por: Chen, Enni, et al.
Publicado: (2023)

T63 induces apoptosis in nasopharyngeal carcinoma cells through mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway
por: Liu, Qin, et al.
Publicado: (2020)

Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis
por: Zhang, Yuan, et al.
Publicado: (2021)

PRDX6 Inhibits Neurogenesis through Downregulation of WDFY1-Mediated TLR4 Signal
por: Yeo, In Jun, et al.
Publicado: (2018)

PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase
por: Ahmed, Wareed, et al.
Publicado: (2018)

Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation
por: Zhu, Jin-Feng, et al.
Publicado: (2018)

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
por: Fu, Jiao, et al.
Publicado: (2013)

Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway
por: Kim, Chang Min, et al.
Publicado: (2016)

siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway
por: Ma, Yini, et al.
Publicado: (2019)

MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling
por: Shen, Qiushuo, et al.
Publicado: (2022)

Fibronectin 1 inhibits the apoptosis of human trophoblasts by activating the PI3K/Akt signaling pathway
por: Ji, Jinlong, et al.
Publicado: (2020)

ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
por: Chen, Qianping, et al.
Publicado: (2020)

As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2022)

PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas
por: Makker, Annu, et al.
Publicado: (2016)

Pre-treatment with angiotensin-(1–7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts
por: Lin, Yu-Tsai, et al.
Publicado: (2018)

PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage
por: Liu, Wenwen, et al.
Publicado: (2021)

SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
por: Huang, Jianyi, et al.
Publicado: (2022)

AMPH1 functions as a tumour suppressor in ovarian cancer via the inactivation of PI3K/AKT pathway
por: Chen, Yajun, et al.
Publicado: (2020)

SOX2 recruits KLF4 to regulate nasopharyngeal carcinoma proliferation via PI3K/AKT signaling
por: Tang, Jianming, et al.
Publicado: (2018)

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
por: Hu, Qian, et al.
Publicado: (2018)

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
por: Dai, Youyi, et al.
Publicado: (2017)

Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
por: Hao, Xiang-lin, et al.
Publicado: (2019)

PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia
por: Zhang, Zhen, et al.
Publicado: (2018)

Indole-3-carbinol inhibits nasopharyngeal carcinoma cell growth in vivo and in vitro through inhibition of the PI3K/Akt pathway
por: MAO, CHENG-GANG, et al.
Publicado: (2014)

Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells
por: WANG, KE-FENG, et al.
Publicado: (2015)

Downregulation of FHL1 protein in glioma inhibits tumor growth through PI3K/AKT signaling
por: Li, San-Zhong, et al.
Publicado: (2020)

ACSL1 Inhibits ALV-J Replication by IFN-Ⅰ Signaling and PI3K/Akt Pathway
por: Zhang, Qihong, et al.
Publicado: (2021)

CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
por: Jin, Qianxu, et al.
Publicado: (2022)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021)

Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia
por: Romanello, Karen S., et al.
Publicado: (2018)

CHL1 suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and Merlin
por: Chen, Juan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rjdho7jqi8e9hdcedt2mf6jpdg